As April concluded, short interest in small-cap healthcare stocks with market capitalizations below $2 billion increased significantly, indicating a rise in bearish sentiment toward these highly volatile equities.

According to recent data, the healthcare sector stocks with the highest short interest at the beginning of May include Sensei Biotherapeutics, KalVista Pharmaceuticals, and GlucoTrack. These companies generally face skepticism regarding clinical trial outcomes and balance sheet strength, making them primary targets for short sellers. Data shows that the Health Care Select Sector SPDR Fund (XLV) has declined 6.23% year-to-date, while the S&P 500 index has risen 5.62% over the same period, highlighting the sector's underperformance.

Among stocks with lower short interest, Beyond Air and Polaryx Therapeutics ranked highest. Analysts note that elevated short positions reflect investor concerns about the development pipelines and financial health of small biotech companies, particularly in the current market environment where firms lacking stable cash flow are more vulnerable to short selling.

It is noteworthy that both Sensei Biotherapeutics (SNSE) and KalVista Pharmaceuticals (KALV), mentioned in the table, were listed as high short interest targets in search report data from May 3. Investors should remain cautious of potential short squeeze risks associated with stocks exhibiting high short interest ratios.